US Patent Issued to Bayer CropScience on Jan. 20 for "Fusion proteins, recombinant bacteria, and exosporium fragments for pest control and plant health" (California, North Carolina Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,323, issued on Jan. 20, was assigned to Bayer CropScience LP (St. Louis).

"Fusion proteins, recombinant bacteria, and exosporium fragments for pest control and plant health" was invented by Damian Curtis (Davis, Calif.) and Kevin Bugg (Apex, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a fusion protein having a targeting sequence, exosporium protein, or exosporium protein fragment that targets the fusion protein to the exosporium of a recombinant Bacillus cereus family member and an enzyme having serine protease activity, wherein the enzyme having serine protease activity is from Bacillus firmus or is a varian...